Itonis to Ship More Emesyl™ Nausea Relief to Hensley Brothers Distribution, LLC

 

LAGUNA HILLS, CA - February 03, 2015 - InvestorsHub NewsWire - Itonis, Inc. (OTC PINKSHEETS: ITNS)

 

Itonis, Inc. announced today that Hensley Brothers Distribution, LLC (an Itonis distributor) has requested additional shipments of Emesyl™ Nausea Relief. 

 

"We take this as an indicator of the market viability of the product," said Mark Cheung, CEO of Itonis.    He added, "To receive this request is quite encouraging considering the product had only recently entered the market."
 

Emesyl™ Nausea Relief first became available publicly on Amazon.com for sale orders.  (http://www.amazon.com/Itonis-Pharmaceuticals-EMESYL-Nausea-Relief/dp/B00SZ423XA/ref=sr_1_2?ie=UTF8&qid=1422946405&sr=8-2&keywords=emesyl)
 

Additionally, Hensley Brothers Distribution  “has stepped up [its] roll out of Emesyl™ Nausea Relief to retailers in Lodi, California” as part of its efforts to place Emesyl™ Nausea Relief “into national big box retail and the travel and tourist distribution network,” said Steven Hensley, Vice-President of Hensley Brothers Distribution.  (http://www.accesswire.com/viewarticle.aspx?id=425483)

 

 

About Emesyl™

www.itonisholdings.com/emesyl

 

 

About Itonis Pharmaceuticals

 

Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by Charles Hensley, Ph.D., and its mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations.  He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States.  Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

About Itonis, Inc.

Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on transitioning itself in the past year from acquiring high growth, market niche entrepreneurial companies, to a market leader focused on the distribution of innovative products to the medical and pharmaceutical industry. Please visit www.itonisholdings.com.

 

Safe Harbor:

Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact:

Itonis, Inc.

Office@itonisholdings.com

 

 

 

 

Itonis (PK) (USOTC:ITNS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Itonis (PK) Charts.
Itonis (PK) (USOTC:ITNS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Itonis (PK) Charts.